Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06235359
Other study ID # empyema
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date March 2024
Est. completion date December 2026

Study information

Verified date January 2024
Source Assiut University
Contact Islam abdelfatah, resident
Phone 01024984239
Email Islam.abdelfatah.097@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Is intercostal tube enough in management of empyema ?


Description:

Empyema refers to presence of pus in the pleural space -Causes Primary: bacterial Pneumonia (staph aureus, strept pneumonia , H.influenza) , TB Secondry : PostTraumati postoperative :open heart , esophageal, mediastinum , lung rupture of lung absess -pathophysiology and stages During an inflammatory process such as pneumonia, there is an increase in fluid production in the pleural cavity known as the exudate stage. As the disease progresses microorganisms, usually bacteria, can colonize the fluid and generated an empyema. This fluid is characterized by elevated lactate dehydrogenase, proteins, neutrophils, and dead cells. Macroscopically is a thick opaque fluid found in the fibrinopurulent stage. After the resolution of the infection and as a consequence of the inflammation, there is a process of fibrosis that can lead to restriction of the lung parenchyma which is stage of chronic organization


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 100
Est. completion date December 2026
Est. primary completion date November 2026
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - patients admitted to Assuit university Hospital and diagnosed with empyema Exclusion Criteria: - Patient diagnosed with Post-operative empyema - Patient diagnosed with post traumatic empyema - Patient diagnosed with Bronchopleural fistula - Patient diagnosed with TB

Study Design


Related Conditions & MeSH terms


Intervention

Device:
intercostal tube
A chest tube is a hollow, flexible tube placed into the chest. It acts as a drain. Chest tubes drain blood, fluid, or air from around your lungs, heart, or esophagus. The tube around your lung is placed between your ribs and into the space between the inner lining and the outer lining of your chest cavity. This is called the pleural space. It allows your lungs to fully expand.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

References & Publications (1)

Ali I, Unruh H. Management of empyema thoracis. Ann Thorac Surg. 1990 Sep;50(3):355-9. doi: 10.1016/0003-4975(90)90474-k. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary To find best way to drain the pus in the pleural space To find best way to drain the pus in the pleural space baseline
See also
  Status Clinical Trial Phase
Recruiting NCT00103766 - Alteplase for Treatment of Empyema and Complicated Parapneumonic Effusion N/A
Completed NCT01178580 - Procoagulant Activity in Patients With Community Acquired Pneumonia, Pleural Effusion and Empyema N/A
Recruiting NCT00313066 - Comparison the Level of CTGF Protein and Related Cytokine in Pleural Effusion Phase 4
Completed NCT03468933 - Fibrinolysis Compared to Thoracoscopy for Pleural Infection Phase 4
Completed NCT03167723 - Prospective Evaluation of 14F Thal Tube vs 28 French Chest Tube for Hemothorax and Use of Maximum Barrier Precautions N/A
Completed NCT00323531 - Thoracoscopy Versus Fibrinolysis in Children With Empyema Phase 2/Phase 3
Not yet recruiting NCT03859206 - Medical Thoracoscopy Versus Tube Thoracostomy in Management of Empyema . N/A
Recruiting NCT01625247 - Drainage is Not Necessary Procedure After Laparoscopic Cholecystectomy Due to Severe Acute Cholecystitis Phase 3
Completed NCT00798278 - Urokinase Versus Video-assisted Thoracoscopic to Treat Complicated Parapneumonic Empyema in Childhood Phase 3
Not yet recruiting NCT04695275 - Clinical Feature and Microbiology Characteristics of Empyema in Children
Recruiting NCT05620329 - UNC Pleural Fluid Registry
Withdrawn NCT01862458 - Empyema Treated With tPA & DNAse Phase 3
Completed NCT02446782 - Efficacy and Safety of Prophylactic Use of an Antibiotic for Medical Thoracoscopy Phase 4
Completed NCT02014077 - VATS ( Video-Assisted Thoracoscopy) Compared to Reinsertion of a Thoracostomy Tube for Persistent Haemothorax N/A
Terminated NCT01287013 - Comparing Xperguide vs. Conventional Methods During Percutaneous Image Guided Procedures N/A
Recruiting NCT04193241 - Suturing With U-Technique Versus Un-Reapproximated Wound Edges During Removal of Closed Thoracostomy Tube Drain N/A
Not yet recruiting NCT06132997 - Medical Thoracoscopy in Treatment Outcomes of Empyema Management N/A
Completed NCT01261546 - Clinical Trial Corticoids For Empyema And Pleural Effusion In Children Phase 2
Completed NCT04350502 - Pharmacokinetics and Pleural Fluid Penetration of Amoxicillin and Clavulanic Acid in Patients With Pleural Infections N/A
Completed NCT01522885 - KatGuide Method Versus Conventional Method at Insertion of Chest Tube Phase 3